MeVis Medical Solutions AG / Product Launch
04.09.2009
Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
With its new syngo BreVis and syngo BreVis Biopsy software, MeVis continues
to expand its position as the world's leader in image-based breast
diagnostics
- syngo BreVis enables a variety of new clinical functions for diagnostic
reporting using syngo workplaces, which are also part of the new MAGNETOM
Espree-Pink magnetic resonance breast scanner from Siemens
- syngo BreVis Biopsy simplifies planning for surgical interventions
- The software applications offer increased clinical efficiency through
precise, streamlined workflows
- The software applications improve multi-modality diagnostics;
ultrasound or radiography images can be viewed along with MR images
Bremen, September 4, 2009 - MeVis Medical Solutions AG [ISIN:
DE000A0LBFE4], a software specialist for medical imaging, announced today
the initial licensing of syngo BreVis and syngo BreVis Biopsy, diagnostic
reporting and intervention software developed by MeVis BreastCare in a
joint venture with Siemens.
The new MeVis BreastCare software applications are available through
Siemens on syngo workplaces for all MAGNETOM magnetic resonance scanners -
including MAGNETOM Espree-Pink, the dedicated breast scanner. This new MRI
system from Siemens was specially designed for breast cancer diagnostics
and is characterized in particular by its high comfort levels for patients.
With 1.3 million incidences worldwide, breast cancer is the most frequently
occurring tumor. In Germany and Europe, breast cancer represents almost 30
percent of all cancer cases.
'With syngo BreVis and syngo BreVis Biopsy, the MeVis experts have proven
their extensive know-how extending to our clinical MR applications,' said
Walter Märzendorfer, head of Magnetic Resonance, Siemens Healthcare. 'Our
flexible coil solution for the MAGNETOM Espree-Pink is ideally complemented
by the workflow-oriented diagnostic reporting software from MeVis.'
The software applications are seamlessly integrated into the Siemens syngo
platform and do not require a separate diagnostic workstation. They provide
a range of important clinical functions that simplify the diagnostic
evaluation of MR images for radiologists and, if necessary, removal of
tissue samples when findings are ambiguous. All functions are clearly
arranged as symbols on the process-oriented user interface according to the
principle of tabbed browsing and are available immediately at the press of
a button.
In addition to the various display modalities, syngo BreVis offers the
opportunity for spontaneous post-processing of image data as well as
various tools for enhanced diagnostic support. The diagnostic reporting
software also includes features to further streamline clinical workflow.
These include, for example, the automatic display of individual images
during the image acquisition process.
Automatic image hanging - that is, the arrangement of images on the monitor
- is based on the corresponding clinical process. This enables optimal
inclusion into the clinical workflow. Using special computer algorithms,
series of patient image data can be displayed in a suitable manner. For
example, the wash-in and wash-out of contrast agent in tissue are
visualized using color values.
Syngo BreVis supports the semi-automatic creation of diagnostic reports,
including BI-RADS reports. The Breast Imaging Reporting and Data System
(BI-RADS) developed by the American College of Radiology (ACR) enables a
classification of diagnostic findings that can be subsequently stored in
the respective hospital PACS systems (Picture Archiving and Communication
Systems) and called up later as required.
The optional syngo BreVis Biopsy intervention software supports the
planning of MR-guided biopsies, as well as the placement of guide wires to
prepare for the resection of breast tumors. Based on a planning scan, the
software automatically calculates the device coordinates for a positioning
unit. The precise area of breast tissue to be sampled or removed via biopsy
needle is reached in this way. The calculated coordinates are displayed
graphically and numerically on-screen for easy printout. The software
supports a range of popular positioning devices and biopsy needles from
different manufacturers.
'We are very pleased with this important expansion of our partnership with
Siemens in the area of magnetic resonance imaging,' said Dr. Carl J. G.
Evertsz, Chairman of the Executive Board of MeVis Medical Solutions AG and
President of the MeVis BreastCare joint venture with Siemens. 'Together
with the recently introduced diagnostic reporting software for the ACUSON
S2000 automated ultrasound breast volume scanner and our many years of
close cooperation in digital mammography and tomosynthesis with the syngo
MammoReport product, we have moved a major step forward in the direction of
real multi-modality diagnostics.'
A press picture for this release is available at:
http://www.mevis.de/mms/en/press_material.html
********************************************************************
MeVis Medical Solutions is one of the world's leading independent
manufacturers and vendors of software products for medical imaging,
particularly digital radiology. Over the past few years, there has been an
enormous increase in the complexity and volume of medical imaging data
derived from digital imaging processes such as computed tomography (CT) and
magnetic resonance imaging (MRI). MeVis Medical Solution's products analyze
and process this data in such a way as to provide attending physicians with
crucial information for early detection, diagnosis and intervention in the
areas of cancer and lung diseases as well as neurological conditions. The
Company develops its disease-oriented software solutions in close
consultation with the world's leading medical experts and original
equipment makers in the medical technology sector and primarily markets
this software via these partnerships.
Established in 2001 as a joint venture between MeVis Medical Solutions AG
and Siemens AG, MeVis BreastCare is active in image-based breast cancer
screening and diagnosis and plays a leading international role in this
area.
********************************************************************
04.09.2009 |[![CDATA[|[a href="http://www.dgap.de"|]Financial News transmitted by DGAP|[/a|]]]|]
---------------------------------------------------------------------------
Language: English
Company: MeVis Medical Solutions AG
Universitätsallee 29
28359 Bremen
Deutschland
Phone: +49 421 330 74-0
Fax: +49 421 330 74-50
E-mail: ir@mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, München, Düsseldorf, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------------
DGAP-News: MeVis Medical Solutions joint venture MeVis BreastCare announces initial licensing of the new breast diagnostic reporting and intervention software to Siemens, its joint venture partner:
| Source: EQS Group AG